MATCAP2
gene geneOn this page
Also known as TMCP2
Summary
MATCAP2 (microtubule associated tyrosine carboxypeptidase 2, HGNC:22206) is a protein-coding gene on chromosome 7p14.2, encoding Putative tyrosine carboxypeptidase MATCAP2 (Q8NCT3). Putative tyrosine carboxypeptidase.
Predicted to enable carboxypeptidase activity; metal ion binding activity; and metallopeptidase activity. Predicted to be involved in proteolysis.
Source: NCBI Gene 23366 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 53 total
- MANE Select transcript:
NM_001199706
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22206 |
| Approved symbol | MATCAP2 |
| Name | microtubule associated tyrosine carboxypeptidase 2 |
| Location | 7p14.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TMCP2 |
| Ensembl gene | ENSG00000164542 |
| Ensembl biotype | protein_coding |
| OMIM | 619896 |
| Entrez | 23366 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 10 protein_coding, 3 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000297063, ENST00000317020, ENST00000338533, ENST00000415803, ENST00000429651, ENST00000431396, ENST00000436884, ENST00000440378, ENST00000453212, ENST00000480192, ENST00000483360, ENST00000483526, ENST00000493327, ENST00000854123
RefSeq mRNA: 6 — MANE Select: NM_001199706
NM_001100425, NM_001199706, NM_001199707, NM_001199708, NM_001300956, NM_015314
CCDS: CCDS43570, CCDS47573, CCDS56482, CCDS56483, CCDS56484, CCDS75583
Canonical transcript exons
ENST00000440378 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001085345 | 36330982 | 36331079 |
| ENSE00001783169 | 36324152 | 36326918 |
| ENSE00003462853 | 36336154 | 36336297 |
| ENSE00003498321 | 36366916 | 36367240 |
| ENSE00003513695 | 36356902 | 36357590 |
| ENSE00003573895 | 36333856 | 36334161 |
| ENSE00003637857 | 36335046 | 36335178 |
Expression profiles
Bgee: expression breadth ubiquitous, 249 present calls, max score 90.21.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.6192 / max 136.1671, expressed in 1243 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 83567 | 7.4096 | 1207 |
| 83568 | 0.2096 | 106 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| choroid plexus epithelium | UBERON:0003911 | 90.21 | gold quality |
| bronchial epithelial cell | CL:0002328 | 88.69 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.67 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 87.26 | gold quality |
| cortical plate | UBERON:0005343 | 87.16 | gold quality |
| adrenal tissue | UBERON:0018303 | 85.11 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.95 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 84.78 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 83.59 | gold quality |
| cerebellar cortex | UBERON:0002129 | 83.49 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 83.45 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.39 | gold quality |
| cerebellum | UBERON:0002037 | 83.28 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 82.80 | gold quality |
| right testis | UBERON:0004534 | 82.71 | gold quality |
| testis | UBERON:0000473 | 82.22 | gold quality |
| left testis | UBERON:0004533 | 82.07 | gold quality |
| bronchus | UBERON:0002185 | 81.78 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.78 | gold quality |
| pancreas | UBERON:0001264 | 80.51 | gold quality |
| body of stomach | UBERON:0001161 | 80.40 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 80.36 | gold quality |
| right adrenal gland | UBERON:0001233 | 79.69 | gold quality |
| body of pancreas | UBERON:0001150 | 79.39 | gold quality |
| left adrenal gland | UBERON:0001234 | 79.34 | gold quality |
| cerebellar vermis | UBERON:0004720 | 79.07 | gold quality |
| stomach | UBERON:0000945 | 79.00 | gold quality |
| adrenal gland | UBERON:0002369 | 78.72 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 78.66 | gold quality |
| adrenal cortex | UBERON:0001235 | 78.55 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-110499 | no | 20.74 |
| E-ANND-3 | no | 6.16 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
120 targeting MATCAP2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | matcap2 | ENSDARG00000057227 |
| mus_musculus | Matcap2 | ENSMUSG00000036411 |
| rattus_norvegicus | Matcap2 | ENSRNOG00000026979 |
Paralogs (1): MATCAP1 (ENSG00000196123)
Protein
Protein identifiers
Putative tyrosine carboxypeptidase MATCAP2 — Q8NCT3 (reviewed: Q8NCT3)
All UniProt accessions (4): C9JGM1, C9JWZ6, E9PE22, Q8NCT3
UniProt curated annotations — full annotation on UniProt →
Function. Putative tyrosine carboxypeptidase.
Cofactor. Binds 1 zinc ion per subunit.
Domain organisation. Putative metalloprotease with an atypical HExxxH zinc-binding motif instead of HExxH, which interrupts the active site-containing helix without affecting the integrity of the catalytic site arrangement.
Isoforms (6)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NCT3-1 | 1 | yes |
| Q8NCT3-2 | 2 | |
| Q8NCT3-3 | 3 | |
| Q8NCT3-4 | 4 | |
| Q8NCT3-5 | 5 | |
| Q8NCT3-6 | 6 |
RefSeq proteins (6): NP_001093895, NP_001186635, NP_001186636, NP_001186637, NP_001287885, NP_056129 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012548 | MATCAP | Family |
Pfam: PF08014
UniProt features (13 total): splice variant 5, binding site 3, sequence conflict 2, chain 1, region of interest 1, active site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NCT3-F1 | 59.68 | 0.23 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 332 (nucleophile)
Ligand- & substrate-binding residues (3): 331; 336; 367
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 108 (showing top):
GOMF_METALLOPEPTIDASE_ACTIVITY, BROWNE_HCMV_INFECTION_12HR_UP, WANG_LMO4_TARGETS_DN, ZHAN_MULTIPLE_MYELOMA_LB_UP, FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, GOBP_PROTEOLYSIS, WILCOX_RESPONSE_TO_PROGESTERONE_UP, MORF_FRK, GOMF_CARBOXYPEPTIDASE_ACTIVITY, GOMF_PEPTIDASE_ACTIVITY, GOMF_EXOPEPTIDASE_ACTIVITY, HUTTMANN_B_CLL_POOR_SURVIVAL_UP, CHYLA_CBFA2T3_TARGETS_DN, FOSTER_KDM1A_TARGETS_UP
GO Biological Process (1): proteolysis (GO:0006508)
GO Molecular Function (5): carboxypeptidase activity (GO:0004180), metallopeptidase activity (GO:0008237), metal ion binding (GO:0046872), peptidase activity (GO:0008233), hydrolase activity (GO:0016787)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein metabolic process | 1 |
| exopeptidase activity | 1 |
| peptidase activity | 1 |
| cation binding | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| catalytic activity | 1 |
Protein interactions and networks
STRING
208 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MATCAP2 | CLHC1 | Q8NHS4 | 475 |
| MATCAP2 | ZBTB39 | O15060 | 458 |
| MATCAP2 | MROH6 | A6NGR9 | 445 |
| MATCAP2 | TMEM200B | Q69YZ2 | 417 |
| MATCAP2 | CCSER2 | Q9H7U1 | 412 |
| MATCAP2 | PCDHGA7 | Q9Y5G6 | 407 |
| MATCAP2 | RNF182 | Q8N6D2 | 380 |
| MATCAP2 | RP1 | P56715 | 370 |
| MATCAP2 | ZFYVE28 | Q9HCC9 | 370 |
| MATCAP2 | ZNF385D | Q9H6B1 | 349 |
| MATCAP2 | PCDHB14 | Q9Y5E9 | 348 |
| MATCAP2 | DHX35 | Q9H5Z1 | 338 |
| MATCAP2 | CWH43 | Q9H720 | 331 |
| MATCAP2 | ABLIM2 | Q6H8Q1 | 329 |
| MATCAP2 | FIGNL1 | Q6PIW4 | 324 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MATCAP2 | SHMT2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MATCAP2 | ATP6V1A | psi-mi:“MI:0915”(physical association) | 0.400 |
| PIPSL | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| FTL | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
| KCNE3 | PIK3R2 | psi-mi:“MI:0914”(association) | 0.350 |
| CAMK2A | SMCHD1 | psi-mi:“MI:0914”(association) | 0.350 |
| MATCAP2 | PRKAR2B | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (13): KIAA0895 (Proximity Label-MS), KIAA0895 (Proximity Label-MS), KIAA0895 (Affinity Capture-MS), KIAA0895 (Affinity Capture-MS), MICAL1 (Affinity Capture-MS), PRKAR2B (Affinity Capture-MS), EEF1A2 (Affinity Capture-MS), EFR3B (Affinity Capture-MS), KIAA0895 (Affinity Capture-MS), ACTA2 (Affinity Capture-MS), KIAA0895 (Affinity Capture-MS), KIAA0895 (Cross-Linking-MS (XL-MS)), KIAA0895 (Affinity Capture-RNA)
ESM2 similar proteins: A8MR21, B2RXH8, B7ZW38, F4JGB7, F4K3M6, O60812, O82312, O82387, O82391, P0DMR1, P83946, P93422, P93831, Q0DZT4, Q0WVE8, Q10MI4, Q149N8, Q3ED78, Q5RBK9, Q5VN06, Q66GQ6, Q680I0, Q6K1U0, Q6K1U4, Q6K5I0, Q6NKT5, Q7TP98, Q7X7E9, Q7ZXY4, Q84JE8, Q84UI6, Q8GW46, Q8GYY5, Q8GZ42, Q8L925, Q8N9N2, Q8NCT3, Q8RXT5, Q8S4P4, Q8S4P5
Diamond homologs: Q4V7A9, Q68EN5, Q7TQE7, Q810A5, Q8NCT3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
53 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1288 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:36326914:GAAAC:G | acceptor_gain | 1.0000 |
| 7:36326916:AAC:A | acceptor_gain | 1.0000 |
| 7:36326917:AC:A | acceptor_gain | 1.0000 |
| 7:36326918:CC:C | acceptor_gain | 1.0000 |
| 7:36326919:C:CC | acceptor_gain | 1.0000 |
| 7:36326919:CTGA:C | acceptor_loss | 1.0000 |
| 7:36331076:CACC:C | acceptor_gain | 1.0000 |
| 7:36331078:CC:C | acceptor_gain | 1.0000 |
| 7:36331079:CC:C | acceptor_gain | 1.0000 |
| 7:36331080:C:CA | acceptor_loss | 1.0000 |
| 7:36331081:T:C | acceptor_loss | 1.0000 |
| 7:36334062:T:TA | donor_gain | 1.0000 |
| 7:36334087:G:C | donor_gain | 1.0000 |
| 7:36335040:CCCTA:C | donor_loss | 1.0000 |
| 7:36335041:CCTAC:C | donor_loss | 1.0000 |
| 7:36335042:CTACC:C | donor_loss | 1.0000 |
| 7:36335043:TACCT:T | donor_loss | 1.0000 |
| 7:36335044:ACCTA:A | donor_loss | 1.0000 |
| 7:36335045:CC:C | donor_loss | 1.0000 |
| 7:36335175:CAAT:C | acceptor_gain | 1.0000 |
| 7:36335179:C:CC | acceptor_gain | 1.0000 |
| 7:36336128:T:TA | donor_gain | 1.0000 |
| 7:36336156:C:A | donor_gain | 1.0000 |
| 7:36336170:T:A | donor_gain | 1.0000 |
| 7:36336186:T:TA | donor_gain | 1.0000 |
| 7:36336187:C:A | donor_gain | 1.0000 |
| 7:36336294:TAGA:T | acceptor_gain | 1.0000 |
| 7:36336298:C:CC | acceptor_gain | 1.0000 |
| 7:36390041:GGAG:G | donor_gain | 1.0000 |
| 7:36390042:GAG:G | donor_gain | 1.0000 |
AlphaMissense
3413 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:36330987:C:A | G467W | 1.000 |
| 7:36331066:T:A | K440N | 1.000 |
| 7:36331066:T:G | K440N | 1.000 |
| 7:36331067:T:A | K440I | 1.000 |
| 7:36333907:A:G | W419R | 1.000 |
| 7:36333907:A:T | W419R | 1.000 |
| 7:36334120:A:G | W348R | 1.000 |
| 7:36334120:A:T | W348R | 1.000 |
| 7:36335051:T:A | E332V | 1.000 |
| 7:36335055:G:C | H331D | 1.000 |
| 7:36335060:A:G | L329P | 1.000 |
| 7:36335108:A:G | L313P | 1.000 |
| 7:36326851:A:G | F491S | 0.999 |
| 7:36330986:C:A | G467V | 0.999 |
| 7:36330986:C:T | G467E | 0.999 |
| 7:36330987:C:G | G467R | 0.999 |
| 7:36330987:C:T | G467R | 0.999 |
| 7:36331046:C:T | G447E | 0.999 |
| 7:36331056:A:G | Y444H | 0.999 |
| 7:36331064:T:A | D441V | 0.999 |
| 7:36331064:T:G | D441A | 0.999 |
| 7:36331065:C:G | D441H | 0.999 |
| 7:36331068:T:C | K440E | 0.999 |
| 7:36331068:T:G | K440Q | 0.999 |
| 7:36333879:C:T | G428E | 0.999 |
| 7:36333881:C:A | R427S | 0.999 |
| 7:36333881:C:G | R427S | 0.999 |
| 7:36333882:C:A | R427M | 0.999 |
| 7:36333882:C:G | R427T | 0.999 |
| 7:36333884:C:A | K426N | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000045276 (7:36352201 G>A), RS1000120734 (7:36336367 G>A), RS1000137945 (7:36351859 T>C), RS1000180882 (7:36364195 C>T), RS1000228810 (7:36378325 A>C), RS1000263842 (7:36390780 G>T), RS1000267598 (7:36345018 G>A), RS1000402374 (7:36337830 G>C), RS1000405844 (7:36336619 C>G), RS1000447520 (7:36384835 A>G), RS1000521120 (7:36365428 A>C), RS1000637729 (7:36364041 AC>A), RS1000641364 (7:36329786 T>C), RS1000667939 (7:36372509 A>G), RS1000683322 (7:36363848 T>A)
Disease associations
OMIM: gene MIM:619896 | disease phenotypes: MIM:610852
GenCC curated gene-disease
Mondo (1): primary ciliary dyskinesia 6 (MONDO:0012571)
Orphanet (1): Primary ciliary dyskinesia (Orphanet:244)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C567057 | Ciliary Dyskinesia, Primary, 6 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression | 7 |
| trichostatin A | affects expression, increases expression | 2 |
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| ICG 001 | decreases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Cadmium | increases expression, decreases reaction | 1 |
| Cisplatin | decreases expression, affects cotreatment | 1 |
| Doxorubicin | decreases expression | 1 |
| Progesterone | increases expression | 1 |
| Selenium | decreases reaction, increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Magnetite Nanoparticles | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): primary ciliary dyskinesia 6